Wellnex Life Limited reported unaudited revenue results for the first half of fiscal year of 2022. Revenue for the first half of FY22 was up18.5% up on the prior corresponding period (PCP) to $8.84 million (unaudited), with an additional $1.6 million in Purchase Orders received to be invoiced in the second half of 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.031 AUD | +10.71% |
|
+14.81% | +34.78% |
Jun. 05 | Wellnex Life to Launch Medicinal Cannabis Product Range; Shares Fall 3% | MT |
May. 24 | Wellnex Life Partners Chemist Warehouse to Reintroduce Pain Away in New Zealand | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.78% | 27.17M | |
+26.06% | 29.22B | |
+10.70% | 6.16B | |
-17.20% | 4.13B | |
+0.88% | 3.76B | |
-7.74% | 1.71B | |
-5.97% | 1.37B | |
-17.55% | 1.13B | |
-43.13% | 726M | |
+1.56% | 649M |
- Stock Market
- Equities
- WNX Stock
- News Wellnex Life Limited
- Wellnex Life Limited Reports Unaudited Revenue Results for the First Half of Fiscal Year of 2022